A. Noè

Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policy.

M. Roncarolo, A. Biffi, A. Aiuti, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multiple BM harvests in pediatric donors for thalassemic siblings: safety, efficacy and ethical issues

M. Roncarolo, R. Miniero, F. Ciceri, 2008, Bone Marrow Transplantation.

Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan

S. Napolitano, M. Roncarolo, A. Biffi, 2009, British journal of haematology.

High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome

M. Roncarolo, C. Baldoli, A. Biffi, 2010, Italian Journal of Pediatrics.

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia

S. Napolitano, M. Roncarolo, F. Ciceri, 2010, Bone Marrow Transplantation.